Subscribe to RSS
DOI: 10.1055/s-2002-35237
Probes for Narcotic Receptor Mediated Phenomena; 29: Synthesis of rac-(4R,6aR,11bR)-3-Methyl-2,3,4,5,6,6a-hexahydro-1H-4,11b-methanobenzofuro[3,2-d]azocin-10-ol, the para-a Oxide-Bridged Phenylmorphan Isomer, and a New Route to rac-(4R,6aR,11bR)-3-Methyl- 2,3,4,5,6,6a-hexahydro-1H-4,11b-methanobenzofuro[3,2-d]azocin-8-ol, the ortho-a Oxide-Bridged Phenylmorphan Isomer
Publication History
Publication Date:
04 November 2002 (online)
Abstract
A six-step synthesis of the para-a oxide-bridged phenylmorphan isomer rac-(4R,6aR,11bR)-3-methyl-2,3,4,5,6,6a-hexahydro-1H-4,11b-methanobenzofuro[3,2-d]azocin-10-ol (4), was achieved using Okahara’s reagent, 3-chloro-2-methoxymethoxypropene, to prepare the key intermediate 8. Bromination was directed at the desired carbon atom via the correctly positioned ketone moiety in 8. O-Demethylation followed by subsequent displacement of the bromine by the phenolic ion in situ gave ketone 9 that, after reduction to the alcohol and conversion to the bis-mesylate, could be reduced to obtain the desired product. The structure of 4 was unequivocally determined by an X-ray spectroscopic study. A similar sequence of reactions provided a novel, much shorter synthetic route to the known ortho-a oxide-bridged phenylmorphan isomer.
Key words
phenylmorphan - narcotic antagonist - drugs - ring closure - heterocycles
- 2
May EL.Murphy JG. J. Org. Chem. 1955, 20: 257 - 3
May EL.Murphy JG. J. Org. Chem. 1955, 20: 1197 - 4
Bertha CM.Mattson MV.Flippen-Anderson JL.Rothman RB.Xu H.Becketts K.Rice KC. J. Med. Chem. 1994, 37: 3163 - 5
Bertha CM.Flippen-Anderson JL.Rothman RB.Porreca F.Davis P.Xu H.Becketts K.Cha XY.Rice KC. J. Med. Chem. 1995, 38: 1523 - 6
Bertha CM.Ellis M.Flippen-Anderson JL.Porreca F.Rothman RB.Davis P.Xu H.Becketts K.Rice KC. J. Med. Chem. 1996, 39: 2081 - 7
Hashimoto A.Rothman RB.Dersch C.Horel R.Jacobson AE.Rice KC. Drug Alcohol Dependence 2000, 60: S86 - 8
Thomas JB.Zheng X.Brieaddy LE.Burgess JP.Mascarella SW.Fix SE.Cantrell BE.Zimmerman DM.Carroll FI. Tetrahedron Lett. 1998, 39: 7001 - 9
Thomas JB.Zheng XL.Mascarella SW.Rothman RB.Dersch CM.Partilla JS.Flippen-Anderson JL.George CF.Cantrell BE.Zimmerman DM.Carroll FI. J. Med. Chem. 1998, 41: 4143 - 10
Thomas JB.Gigstad KM.Fix SE.Burgess JP.Cooper JB.Mascarella SW.Cantrell BE.Zimmerman DM.Carroll FI. Tetrahedron Lett. 1999, 40: 403 - 11
Burke TR.Jacobson AE.Rice KC.Silverton JV. J. Org. Chem. 1984, 49: 1051 - 12
Burke TR.Jacobson AE.Rice KC.Silverton JV. J. Org. Chem. 1984, 49: 2508 - 13
Burke TR.Jacobson AE.Rice KC.Weissman BA.Huang HC.Silverton JV. J. Med. Chem. 1986, 29: 748 - 14
Yamada K.Jacobson AE.Rice KC. In Problems of Drug Dependence 1991Harris LS. NIDA Research Monograph 119; Washington DC: 1992. p.370 - 15
Berney D. Helv. Chim. Acta 1978, 61: 1110 - 16
Burns RS.Chiueh CC.Markey SP.Ebert MH.Jacobowitz DM.Kopin IJ. Proc. Natl. Acad. Sci. U.S.A. 1983, 80: 4546 - 17
Langston JW.Ballard P.Tertrud JW.Irwin I. Science 1983, 219: 979 - 18
Evans DA.Mitch CH.Thomas RC.Zimmerman DM.Robbey RL. J. Am. Chem. Soc. 1980, 102: 5955 - 19
Gu XP.Nishida N.Ikeda I.Okahara M. J. Org. Chem. 1987, 52: 3192 - 20
Weller DD.Rapoport H. J. Med. Chem. 1976, 19: 1171 - 21
Olieman C.Maat L.Beyerman HC. Recl. Trav. Chim. Pays-Bas 1978, 97/2: 31 - 22
Sheldrick GM. Version 5.03 Ed. Bruker Analytical X-ray Instruments; Madison, WI.: 1997.
References
Current Address: Tanabe Seiyaku Co., Ltd., Medicinal Chemistry Department, Discovery Research Laboratory, 2-50, Kawagishi, 2-Chome, Toda, Saitama, 335-8505, Japan.